1 / 11

Dermatology Diagnostic Devices and Therapeutics Market to Reach US$ 21.1 bn by 2023 as Acute and Chronic Skin Disorders

The global dermatology diagnostic devices market was valued at US$ 0.6 Mn in 2014 and is projected to expand at a CAGR of 6.9% from 2015 to 2023 to reach US$ 1.0 Bn in 2023. Similarly, the global dermatology therapeutics market was valued at US$ 17.5 Bn in 2014 and is projected to expand at a CAGR of 1.9% from 2013 to 2018 and 1.6% from 2018 to 2023 to reach US$ 20.1 Bn in 2023.<br><br>Read Full Report: http://www.transparencymarketresearch.com/dermatology-diagnostic-devices-therapeutics-market.html

SmitaDeshmukh
Download Presentation

Dermatology Diagnostic Devices and Therapeutics Market to Reach US$ 21.1 bn by 2023 as Acute and Chronic Skin Disorders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Transparency Market Research Dermatology Diagnostic Devices and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 Published Date 03-02-2016 105 Page Report Request Sample Buy Now Press Release Dermatology Diagnostic Devices and Therapeutics Market to Reach US$ 21.1 bn by 2023 as Acute and Chronic Skin Disorders Rise Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

  2. Dermatology Diagnostic Devices and Therapeutics Market REPORT DESCRIPTION Dermatology Diagnostic Devices and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 According to a new market report published by Transparency Market Research “Dermatology Diagnostic Devices and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, the global dermatology diagnostic devices market was valued at US$ 0.6 Mn in 2014 and is projected to expand at a CAGR of 6.9% from 2015 to 2023 to reach US$ 1.0 Bn in 2023. Similarly, the global dermatology therapeutics market was valued at US$ 17.5 Bn in 2014 and is projected to expand at a CAGR of 1.9% from 2013 to 2018 and 1.6% from 2018 to 2023 to reach US$ 20.1 Bn in 2023. Browse the full report at: :http://www.transparencymarketresearch.com/dermatology-diagnostic-devices-therapeutics-market.html Dermatology is a branch of medical science that deals with examination and treatment of various disorders and diseases related to the skin, hair, nails, including its surgical aspect. The stakeholders of this market report comprise established original equipment and pharmaceutical product manufacturers, product distributors, and new players who wish to enter the global dermatology diagnostic devices and therapeutics market. This report provides a complete analysis of the global dermatology diagnostic devices and therapeutics market and helps in recognizing several governing factors that impact the market both positively and negatively. Executive summary of the report captures comprehensive insights about every segment considered in this study. It includes a market snapshot offering an insight into the current scenario of the dermatology diagnostic device and dermatology market in terms of current and future market size along with growth rate. The market overview segment provides thorough information on the trends in the usage pattern of various diagnostic devices and therapeutics for dermatology, such as drivers, restraints, and growth opportunities that presently regulate the dynamics of the overall market. Competitive analysis tools such as Porter’s Five Forces analysis and market attractiveness analysis have also been incorporated in this study to provide 2 Transparency Market Research

  3. Dermatology Diagnostic Devices and Therapeutics Market analysis about the level of competition within the dermatology diagnostic devices and therapeutics market. Competitive intelligence tools such as market attractiveness analysis have also been included in the market overview section of the report to deliver a clear understanding of the most attractive and fastest growing device segment, drug class and region globally for dermatology diagnostic devices and therapeutics. Get Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=8908 Market share analysis thus provided in this study is in context with major players of dermatology diagnostic devices and dermatology therapeutics operating in the market; this would help new players to understand the key business models and geographical presence and identify the specific product lines of existing companies to establish a strong presence in the dermatology diagnostic devices and therapeutics market. Furthermore, the research comprises a chapter on pipeline analysis for this industry that includes tabular representation of phase I and phase II candidates along with sales forecast potential drugs that are undergoing phase III clinical trials and are expected to be marketed during the forecast period. The global dermatology diagnostic devices and therapeutics market has been segmented based on various dermatology diagnostic devices, drug classes used for treating dermatology disorders, and geographies. Based on dermatology diagnostic products the market has been categorized into dermatoscopes, microscopes & trichoscopes, and imaging equipment. Based on drug class the dermatology therapeutics market has been segmented into antibacterials, antifungal agents, antiviral agents, corticosteroids, retinoids, immunosuppresants, biologics. The market size for the period from 2013 to 2023 has been provided for each of the devices and therapeutics categories mentioned above in terms of US$ Mn. Along with the market size that was projected considering 2014 as the base year and 2013 as the historical year, the CAGR (%) of each market segment for the forecast period from 2015 to 2023 (for therapeutics forecast period is from 2013 to 2018 and 2018 to 2023) has also been provided. Geographically, the dermatology diagnostic devices and therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & North Africa, and Rest of the World. North America has been further segmented into the U.S. and Canada; Europe into Germany, the U.K. and Rest of Europe; Asia Pacific into China, Japan, India, Australia, and Rest of Asia Pacific; Latin America into 3 Transparency Market Research

  4. Dermatology Diagnostic Devices and Therapeutics Market Brazil and Rest of Latin America; Middle East & North Africa (MENA) into Egypt, Kuwait, UAE, Saudi Arabia, and rest of MENA; and Rest of the world. The market revenue of dermatology diagnostic devices and therapeutics for each geographical region for 2014 and 2023 along with forecast from 2015 to 2023 in respective regions in terms of USD Mn, has been explained in the geography section of the report. This market study concludes with profiles of key players in the global dermatology diagnostic devices and dermatology market. The report summarizes the companies in terms of overview, financial overview, product and services portfolio, key business strategies, and recent developments. The major players profiled in the section are Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Dino-Lite Europe/IDCP B.V., Galderma S.A., Genentech, a Roche Company, GlaxoSmithKline plc (Stiefel Laboratories, Inc.), LEO Pharma A/S, Michelson Diagnostics Ltd., Novartis International AG, and Valeant Pharmaceuticals International, Inc. The global dermatology diagnostic devices and therapeutics market has been segmented as follows: Dermatology Diagnostic Devices Market, by Products Dermatoscopes • Microscopes and Trichoscopes • Imaging Equipment • Dermatology Therapeutics Market, by Drug Class Antibacterials • Antifungal Agents • Antiviral Agents • Corticosteroids • Retinoids • Immunosuppresants • 4 Transparency Market Research

  5. Dermatology Diagnostic Devices and Therapeutics Market Biologics • Dermatology Therapeutics Market: Pipeline Overview, Phase 1, 2, and 3 Tabular Representation: Phase 1 and Phase 2 Candidates • Pipeline Analysis and Forecast: Phase 3 • LAS41008 ◦ Ixekizumab ◦ Dupilumab ◦ CD5789 ◦ IDP-118 ◦ Dermatology Diagnostic Devices and Therapeutics Market, by Geography North America • U.S. ◦ Canada ◦ Europe • Germany ◦ U.K. ◦ Rest of Europe ◦ Asia Pacific (APAC) • China ◦ 5 Transparency Market Research

  6. Dermatology Diagnostic Devices and Therapeutics Market Japan ◦ India ◦ Australia ◦ Rest of Asia Pacific ◦ Latin America • Brazil ◦ Rest of Latin America ◦ Middle East & North Africa (MENA) • Egypt ◦ Kuwait ◦ UAE ◦ Saudi Arabia ◦ Rest of MENA ◦ Rest of the World (RoW) • Browse Full Press Release @ http://www.transparencymarketresearch.com/pressrelease/dermatology- diagnostic-devices-therapeutics-market.htm 6 Transparency Market Research

  7. Dermatology Diagnostic Devices and Therapeutics Market TABLE OF CONTENT Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.4 Assumptions Chapter 2 Executive Summary 2.1 Global Dermatology Diagnostic Devices and Therapeutics Market, Size and Forecast, By Revenue, 2013–2023 (US$ Mn) 2.2 Global Dermatology Diagnostic Devices Market, by Product, 2014 (US$ Mn) 2.3 Global Dermatology Therapeutics Market, by Drug Class, 2014 (US$ Mn) 2.4 Global Market Share by Geography (Diagnostic Devices), 2014 and 2023 (Value %) 2.5 Global Market Share by Geography (Therapeutics), 2014 and 2023 (Value %) 2.6 Dermatology Diagnostic Devices Market Snapshot 2.7 Dermatology Therapeutics Market Snapshot Chapter 3 Dermatology Diagnostic Devices and Therapeutics Market Overview 3.1 Market Overview 3.2 Market Drivers 3.2.1 Driver 1 - Rising prevalence of acute and chronic skin disorders 3.2.2 Driver 2 - Changing patient pool demographics and increasing geriatric population 3.2.2.1 Percentage of Population (for U.S., China, Japan, and India) over the age of 65: 1980–2050 3.2.2.2 Global Percentage Change in the World’s Population by Age: 2010 – 2050 7 Transparency Market Research

  8. Dermatology Diagnostic Devices and Therapeutics Market 3.3 Restraints 3.3.1 Restraint 1 - Implementation of the Affordable Care Act and medical device tax 3.3.2 Restraint 2 -Patent expirations of major drugs during the forecast period expected to impede market growth 3.4 Opportunities 3.4.1 Opportunity 1 - Disposable income and growing patient pool in emerging markets 3.5 Porter’s Five Forces Analysis 3.6 Company Market Share 3.7 Market Attractiveness Analysis 3.8 Overview of Skin Diseases Chapter 4 Market Segmentation – By Products 4.1 Introduction 4.1.1 Global Dermatology Diagnostic Devices Market, by Product, 2013–2023 (US$ Mn) 4.2 Global Dermatoscopes Market Revenue for Dermatology Diagnostic, 2013–2023 (US$ Mn) 4.3 Global Microscopes and Trichoscopes Market Revenue for Dermatology Diagnostic, 2013–2023 (US$ Mn) 4.4 Global Imaging Equipment Market Revenue for Dermatology Diagnostic, 2013–2023 (US$ Mn) Chapter 5 Market Segmentation – By Drug Class 5.1 Introduction 5.1.1 Global Dermatology Therapeutics Market, by Drug Class, 2013–2023 (US$ Mn) 5.2 Global Antibacterials for Dermatology Market Revenue, 2013–2023 (US$ Mn) 5.3 Global Antifungal Agents for Dermatology Market Revenue, 2013–2023 (US$ Mn) 5.4 Global Antiviral Agents for Dermatology Market Revenue, 2013–2023 (US$ Mn) 5.5 Global Corticosteroids for Dermatology Market Revenue, 2013–2023 (US$ Mn) 8 Transparency Market Research

  9. Dermatology Diagnostic Devices and Therapeutics Market 5.6 Global Retinoids for Dermatology Market Revenue, 2013–2023 (US$ Mn) 5.7 Global Immunosuppresants for Dermatology Market Revenue, 2013–2023 (US$ Mn) 5.8 Global Biologics for Dermatology Market Revenue, 2013–2023 (US$ Mn) Chapter 6 Market Segmentation – By Pipeline Assessment 6.1 Global Dermatology Therapeutics Market: Pipeline Overview, Phase I, II,and III 6.2 Global Dermatology Therapeutics Market, Pipeline Analysis and Forecast, Year of Launch till 2023 (US$ Mn) Chapter 7 Market Segmentation – By Region 7.1 Overview 7.1.1 Global Dermatology Diagnostic Devices Market Revenue, by Geography, 2013–2023 (US$ Mn) 7.1.2 Global Dermatology Therapeutics Market Revenue, by Geography, 2013–2023 (US$ Mn) 7.2 North America 7.2.1 North America Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn) 7.2.2 North America Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn) 7.3 Europe 7.3.1 Europe Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn) 7.3.2 Europe Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn) 7.4 Asia Pacific 7.4.1 APAC Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn) 7.4.2 APAC Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn) 7.5 Latin America 7.5.1 Latin America Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn) 7.5.2 Latin America Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn) 9 Transparency Market Research

  10. Dermatology Diagnostic Devices and Therapeutics Market 7.6 Middle East & North Africa 7.6.1 MENA Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn) 7.6.2 MENA Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn) 7.7 Rest of the World 7.7.1 RoW Dermatology Diagnostic Devices Market Revenue, 2013–2023 (US$ Mn) 7.7.2 RoW Dermatology Therapeutics Market Revenue, 2013–2023 (US$ Mn) Chapter 8 Historical Snapshot and Current Trends Chapter 9 Company Profiles 9.1 Agfa-Gevaert N.V. 9.2 Astellas Pharma, Inc. 9.3 Cutera, Inc. 9.4 Dino-Lite Europe/IDCP B.V. 9.5 Galderma S.A. 9.6 Genentech, a Roche Company 9.7 GlaxoSmithKline plc (Stiefel Laboratories, Inc.) 9.8 LEO Pharma A/S 9.9 Michelson Diagnostics Ltd. 9.10 Novartis International AG 9.11 Valeant Pharmaceuticals International, Inc. About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward- looking insight for thousands of decision makers. 10 Transparency Market Research

  11. Dermatology Diagnostic Devices and Therapeutics Market Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ 11 Transparency Market Research

More Related